TipRanks
Go Ultimate55% OFF

Kiniksa Pharmaceuticals (KNSA) Balance Sheet

Kiniksa Pharmaceuticals Balance Sheet

Kiniksa Pharmaceuticals's total assets for Q3 2026 were $983.24M, an increase of 9.72% from the previous quarter. KNSA total liabilities were $273.05M for the fiscal quarter, a 12.85% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 763.63M$ 580.55M$ 526.32M$ 459.67M$ 232.80M
$ 196.03M$ 142.12M$ 87.48M$ 63.52M$ 47.76M
$ 567.61M$ 438.44M$ 438.84M$ 396.15M$ 185.04M

Currency in USD

Kiniksa Pharmaceuticals Debt to Assets

0300M600M900M0 %120 %240 %360 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets